SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending due to a 12-state antitrust lawsuit led by California aimed at blocking its $110 billion merger with Warner Bros. Discovery, a move the community is actively debating as either a politically motivated shakedown or a genuine concern over market competition. Investors remain divided and anxious, with many discussing the potential for costly financial penalties and extended legal delays, while some see the current share price dip as a long-term accumulation opportunity despite the ongoing regulatory uncertainty.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending as investors react to the company's recent acquisition agreement with Tempus AI, which has sparked significant debate regarding the valuation and the long-term strategic implications of the all-stock deal. The community is actively discussing the potential impact of the merger, the role of institutional shareholders, and the future of the company's precision oncology technology in a consolidating market.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin remains a highly polarizing asset as the community debates whether it represents a long-term investment opportunity or a speculative trap. While some vocal holders continue to advocate for its potential to reach new highs, others are actively dismissing the project and expressing frustration over the lack of sustained price momentum.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is seeing increased investor attention as the market reacts to multiple strategic catalysts, including its recent TSX uplisting and expanding partnerships aimed at commercializing its proprietary Hydrochemolytic technology. The community is actively discussing the stock's long-term potential in circular economy and oil upgrading verticals, with many participants focused on monitoring institutional accumulation and key technical support levels amidst recent volatility.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant market volatility driven by the announcement of its strategic acquisition of Personalis, an all-stock deal that has sparked concerns regarding share dilution and integration risks. Community discussion remains polarized, with some investors viewing the acquisition as a long-term catalyst for expanding the companys precision medicine and data moat, while others express frustration over the deal structure and the stock's recent downward price action.

ARK ETF Trust - ARK Innovation ETF

ARK Innovation ETF

ARK Innovation ETF is facing significant criticism and volatility as investors scrutinize its heavy exposure to speculative bets like SpaceX and its consistent underperformance relative to major benchmarks. While community discourse remains sharply divided between those calling the fund a failure and others praising the manager's long-term conviction, the active rotation in the portfolio continues to drive intense debate regarding the efficacy of its innovation-focused strategy.

Space Exploration Technologies Corp. (SpaceX) designs, manufactures, and launches advanced rockets and spacecraft, including the fully reusable Starship and Super Heavy rocket system, targeting missions to Earth orbit, the Moon, Mars, and beyond. The company is based in Hawthorne, CA and has subsidiaries in Luxembourg and the United States. The company operates Starlink, a low-Earth orbit satellite constellation that delivers high-speed broadband internet worldwide. SpaceX is dedicated to advancing space technology with the goal of enabling human life on other planets. The company was founded in 2002 by Elon Reeve Musk, Kimbal Musk, Michael Kives. Elon Reeve Musk has been the CEO since 2002.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is currently trending as investors closely monitor the successful 13th Starship test flight and Starlink satellite deployment, weighing these technical milestones against significant concerns regarding valuation and upcoming lock-up share expirations. While the community remains deeply divided, discussions center on whether the companys long-term potential in heavy-lift capabilities and internet infrastructure justifies its current market position despite ongoing skepticism from bears.

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Eastman Kodak Co.

Eastman Kodak is seeing significant investor attention driven by its strategic pivot toward domestic pharmaceutical manufacturing and the potential for federal government contracts amid heightened onshoring mandates. Community members are actively debating the company's valuation, upcoming earnings catalysts, and the potential impact of new regulatory requirements on its pharmaceutical segment.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as institutional investors accumulate shares amidst significant short interest, with the community focused on the company's long-term potential as a global digital healthcare platform. Investors are closely tracking the integration with Walmart, the expansion of insurance coverage for BetterHelp, and the company's broader push into AI-driven care, weighing these developments against persistent debates over management's execution and the stock's long-term recovery trajectory.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is trending due to anticipation of a pivotal Phase 3 readout for its MDD drug, which investors view as a binary catalyst that could significantly shift the stock's valuation. Community discussion is heavily focused on the stock's potential as a major competitor in the psychedelic space, with debates centered on whether recent price volatility is a setup for a breakthrough or a precursor to further share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
